Intermittent intravenous ibandronate therapy for osteoporosis
The author consecutively considers the introduction of intermittent use of ibandronate (I), by determining its single dose and annual cumulative dose. She presents data on the adequate antiresorptive activity of intermittent treatment, shows it necessary to design an intravenous dosage form of the d...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2008-09-01
|
Series: | Современная ревматология |
Online Access: | https://mrj.ima-press.net/mrj/article/view/175 |